Drug Information

Drug General Information
Drug ID
D0S3WK
Former ID
DIB014120
Drug Name
HRC-302
Synonyms
HML-115; XL-2; Cell therapy, X-Cell Biotech; GDT-CML, Hemosol; Stem cells, X-Cell Biotech; Gamma delta T-cells (selectively expanded), Hemosol; GDT-CML (HRC-302-expanded), Hemosol
Indication Chronic myelogenous leukaemia [ICD9: 205.1; ICD10:C92.1] Discontinued in Phase 1 [547281]
Company
Ontario Inc
Target and Pathway
Target(s) Hemoglobin Target Info Modulator [547282]
KEGG Pathway African trypanosomiasis
Malaria
Reactome Erythrocytes take up carbon dioxide and release oxygen
Erythrocytes take up oxygen and release carbon dioxide
Scavenging of heme from plasma
WikiPathways Binding and Uptake of Ligands by Scavenger Receptors
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes
Factors involved in megakaryocyte development and platelet production
Folate Metabolism
Vitamin B12 Metabolism
Selenium Micronutrient Network
References
Ref 547281Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014790)
Ref 547282Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014790)

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.